TiumBio and Hansoh Pharma: A Breakthrough in ART Development for Merigolix TiumBio announces that its partner, Hansoh Pharma, expands the indications for Merigolix, paving the way for innovative ART treatments to enhance fertility outcomes.

TiumBio and Hansoh Pharma: A Breakthrough in ART Development for Merigolix #South_Korea #Seongnam #Hansoh_Pharma #Merigolix #TiumBio